BBB

Celgene Corporation 4.625% 15-MAY-2044

No trades
See on Supercharts
Overview
Analysis

Key terms


Outstanding amount
‪3.69 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
4.63% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
5.39%
Maturity date
May 15, 2044
Term to maturity
19 years

About Celgene Corporation 4.625% 15-MAY-2044


Issuer
Celgene Corp.
Sector
Health Technology
Industry
Biotechnology
Home page
Issue date
May 15, 2014
FIGI
BBG006G1P4J0
Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases in patients with limited treatment options. There are hundreds of clinical trials at major medical centers evaluating compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma (MM), myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), pancreatic cancer, non-small lung cancer and melanoma. In addition, several compounds are being evaluated as therapies for serious inflammatory diseases such as psoriasis and psoriatic arthritis.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.